| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |